{"SPADE_N_15077": {"Sequence Information": {"Peptide Name": "Feglymycin", "Sequence": "XXVXXXXXVXXFD", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antiviral"], "Binding Target": "1. Membrane Protein\n2. Virus replication\n3. Virus entry\n4. gp120", "Source": "1. Streptomyces sp. DSM 11171", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Feglymycin, a novel inhibitor of the replication of the human immunodeficiency virus. Fermentation, isolation and structure elucidation", "Pubmed ID": "10395273", "Reference": "J Antibiot (Tokyo). 1999;52:374-382", "Author": "Vértesy L, Aretz W, Knauf M, Markus A, Vogel M, Wink J", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/10395273"}, {"Title": "Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120.", "Pubmed ID": "22959895", "Reference": "Virology. 2012;433:308-319", "Author": "Férir G, Hänchen A, François KO, Hoorelbeke B, Huskens D, Dettner F, Süssmuth RD, Schols D", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22959895"}], "SPADE ID": "SPADE_N_15077", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02548", "Similarity": 1.0, "Sequence": "YEALVTSILGKLTGLWHNDSVDFMGHICYFRRRPKIRRFKLYHEGKFWCPGWAPFEGRCKYCVVF"}, {"SPADE_ID": "SPADE_N_09797", "Similarity": 1.0, "Sequence": "QYEALVTSILGKLTGLWHNDSVDFMGHICYFRRRPKIRRFKLYHEGKFWCPGWAPFEGRCKYCVVF"}, {"SPADE_ID": "SPADE_UN_08917", "Similarity": 1.0, "Sequence": "MIGVIFYNTKGNFLRVKCLDCGNQQVVFDRAASYVQCIICGKTLVEPTGGKSKIKAQILEVLD"}], "Hemolytic Activity": "", "Target Organism": "Staphylococcus aureus SG511(MIC=64µg/ml),Staphylococcus aureus 503(MIC=32µg/ml),Staphylococcus epidermidis(MIC=64µg/ml),Streptococcus pyogenes 308A(MIC=32µg/ml),Escherichia coli 078(MIC=>128µg/ml),Pseudomonas aeruginosa ATCC 9027(MIC=>128µg/ml),HIV-1(IC50 REP=3.6µM),HIV-1 NL4-3(IC50 I=0.9µM),HIV-1 IIIB(IC50 I=3.2µM),HIV-2 ROD(IC50 I=1.2µM),HIV-1 BaL(IC50 I=2.9µM)"}}}